Fidelity
Home > Boards > US OTC > Biotechs >

Vivakor, Inc. (VIVK)

VIVK RSS Feed
Add VIVK Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Atlanta1
Search This Board:
Last Post: 4/16/2014 11:01:27 AM - Followers: 71 - Board type: Free - Posts Today: 0

 

Vivakor Inc. 

Overview:

Vivakor, Inc. is a biotechnology holding company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life.

Mission:

Vivakor is Inventing Solutions for Life. Vivakor is dedicated to advancing new ideas that improve life for the individual patient, researcher, clinician, and consumer. We don't create science in a vacuum; we push products to market. Our model of innovation spans the continuum from ideas conception to commercialization. We create solutions that positively impact life.

Business Overview:

Vivakor, Inc. ("Vivakor," the "Company," or "we") is a transdisciplinary research company that develops products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds. We also provide contract research services for third parties. We have developed numerous products and have filed many patents or provisional patents with the United States Patent and Trademark Office (USPTO). We intend to commercialize such products, after completion of any required regulatory approvals, through one of three methods: a sale of the technology, licensing of the product to a manufacturer or distributor or, in some cases, by manufacturing, marketing and directly selling the products ourselves.

Our business model is to be a research hub focused on areas that have both an identified scientific need and a substantial market opportunity. Our company mission is to advance new ideas to improve the quality of life for individual patients, researchers, clinician or consumer. We believe that the development of substantive technologies and cures for complex human conditions, illnesses and diseases require a sophisticated approach with contribution from many areas of scientific expertise typically requiring a lengthier trajectory to market. Our hub approach is intended to provide the necessary environment of transdisciplinary collaboration and cross-pollination to advance this type of research. Our research is anchored by our relationship with collaborative partners and product-specific commercialization strategies. From the commencement of product conception through development, we target specific commercialization strategies and expect to have collaborative partners or licensing arrangements in place for each of our products before completion. We expect this model to offer several advantages to our shareholders, including a more efficient research and development process and a quicker time to market after completion of development.

Our pathway for development of products follows one of two routes to commercialization. First is a short-term path in which products for which an expedited regulatory oversight is available are rapidly pushed to the prototype and alpha testing phase. These projects represent rapidly commercializable technologies and products that we expect will have the potential to generate revenue quickly. Second is a long-term path in which more involved and complex projects are developed. These products typically require substantial regulatory oversight or approval. We anticipate that cash flow generated by the short-term projects will help to fund the long-term projects. These longer incubating projects characteristically represent breakthrough technologies with more risk but higher revenue potential.

 

 

News: http://ir.stockpr.com/vivakor/news-room

SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001450704&type=&dateb=&owner=include&count=40

Website: http://www.vivakor.com/

Matthew Nicosia

Executive Chairman

Matthew Nicosia has served as a director of our Company since November, 2006.  From 2000 to 2007, prior to joining the Company as Executive Chairman of the Board, Mr. Nicosia was the founder and Chief Executive Officer and served as a director of Dermacia, Inc. While founding Dermacia, Inc., in 2002, Mr. Nicosia, co-founded Quantum Sphere, Inc. and served as a director till 2004.  Mr. Nicosia also currently sits on the Board of Directors and is a principal of Integrity, Equity, and is a director of several private companies. Mr. Nicosia received his Bachelor of Arts degree from Brigham Young University and an MBA degree from Pepperdine University.

 

 

Empire Stock Transfer Inc.
Corporate Office:
1859 Whitney Mesa Dr
Henderson, NV 89014

Tel: 702-818-5898

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VIVK
Current Price
Volume:
Bid Ask Day's Range
Wiki
VIVK News: Vivakor Exceeds Expectations on Metals Production for Q1 2014 From Metals Division 04/17/2014 08:54:45 PM
VIVK News: Vivakor Announces Q4 and Year-End Results for Fiscal 2013 03/27/2014 11:43:07 AM
VIVK News: Vivakor Announces Royalty Lease of Precious Metals Mining Claim 03/11/2014 10:15:00 AM
PostSubject
#6859  Sticky Note everything Nicosia touches turns to crap, and shareholders Atlanta1 03/02/13 11:05:57 AM
#7022   It's sleepy time in Nicosiaville. Atlanta1 04/16/14 11:01:27 AM
#7021   I hope we get a nice jump in audi65 03/27/14 12:52:35 PM
#7020   Thanks for the update. Atlanta1 03/27/14 12:41:27 PM
#7019   Vivakor Announces Q4 and Year-End Results for Fiscal 2013 giabull 03/27/14 12:30:42 PM
#7013   BID creepin higheR! :-) Bull Trader 03/13/14 03:51:23 PM
#7012   looking forward to the upcoming year here! Bull Trader 03/13/14 02:53:48 PM
#7011   much wiser people? Atlanta1 03/13/14 02:21:19 PM
#7010   I disagree completely. management is already surrounding themselves Bull Trader 03/13/14 02:20:10 PM
#7009   Not a snowball's chance in hell. Atlanta1 03/13/14 10:51:04 AM
#7008   When VIVK's technology is fully rolled out soon Bull Trader 03/13/14 10:49:28 AM
#7007   i am excellent! i am bid sitting this Bull Trader 03/12/14 03:14:53 PM
#7006   right on been on close radar!I like the DFLY 03/12/14 03:10:54 PM
#7005   yes - it will be interesting to see Atlanta1 03/12/14 03:09:34 PM
#7004   Can't wait for next month here!!! big things coming. Bull Trader 03/12/14 03:08:25 PM
#7003   hearing this is gonna be moving over a Bull Trader 03/12/14 03:06:59 PM
#7002   this company is on the right track. Bull Trader 03/12/14 03:06:21 PM
#7001   this is GREAT NEWS! BIG things gonna happen Bull Trader 03/12/14 03:05:53 PM
#6999   Relax just posting a news here. giabull 03/11/14 11:42:14 AM
#6998   This is freaking hilarious. Atlanta1 03/11/14 10:46:21 AM
#6997   ROFLMFAO This is a total charade. Atlanta1 03/11/14 10:31:55 AM
#6996   Vivakor Announces Royalty Lease of Precious Metals Mining Claim giabull 03/11/14 10:27:20 AM
#6994   Every pubic company that Matt Nicosia touches has Atlanta1 03/11/14 10:07:11 AM
#6993   this is totally untrue. i have seen the Bull Trader 03/11/14 10:04:09 AM
#6990   This piece of crap has a $90 million+ Atlanta1 03/11/14 10:01:27 AM
#6989   The "technology" is basically a garbage can with Atlanta1 03/11/14 09:57:47 AM
#6988   very exciting technology here! Bull Trader 03/11/14 09:53:32 AM
#6987   in the case of VIVK i believe the Bull Trader 03/11/14 09:53:03 AM
#6986   reading the news here... massive potential. Bull Trader 03/11/14 09:50:36 AM
#6985   bid sitting this one!!! Bull Trader 03/11/14 09:50:10 AM
#6984   come on Matt - $VIVK shareholders are ripe Atlanta1 03/07/14 11:07:44 AM
#6983   Come on Matt, where are you boy? Atlanta1 02/19/14 06:14:13 AM
#6982   I don't know, but I hope it's good! audi65 01/28/14 01:49:45 PM
#6981   I wonder what BS Slickosia is cooking up Atlanta1 01/23/14 11:55:34 AM
#6980   Believe me Atlanta, if Nicosia is going to audi65 12/26/13 03:41:39 PM
#6979   If it shot up over $9000, congrats. Atlanta1 12/26/13 03:25:11 PM
#6978   My stock's market value just shot up over audi65 12/26/13 03:18:37 PM
#6977   yep - almost time for Slickosia to start Atlanta1 12/26/13 10:58:30 AM
#6976   VIVKD Capital Change=shs increased by 10 for 1 lovepeople 12/26/13 10:55:45 AM
#6975   So they raise the A/S 34 for 1 LeGoose 12/14/13 01:29:20 AM
#6974   No doubt: "February 5, 2013, Irvine CA, hardlesson 12/13/13 05:09:34 PM
#6973   expect a "vaporization technology" PR soon. Atlanta1 12/13/13 05:04:15 PM
#6972   No problem, that last r/s was extremely excessive, hardlesson 12/13/13 05:02:32 PM
#6971   Thanks for the heads up. Atlanta1 12/13/13 04:54:38 PM
#6970   Forward Split: 09:16 12/16/2013 VIVK Vivakor Inc hardlesson 12/13/13 04:52:29 PM
#6969   This stock is starting get some good buying audi65 12/03/13 05:59:13 PM
#6968   The stock held up pretty well on Friday LeGoose 12/01/13 12:22:17 AM
#6967   Fully diluted, that's only a $3BILLION market cap, lol. LeGoose 11/27/13 09:02:57 PM
#6966   ROFLMFAO thanks for the link. Atlanta1 11/27/13 08:52:03 PM
#6965   A/S increased to 700mm? Looks like LeGoose 11/27/13 08:48:55 PM
#6964   I like to live dangerously, that's why I audi65 11/27/13 03:34:17 PM
PostSubject